Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $589M | $641M | $663M | $732M |
| Revenue growth | — | 8.9% | 3.4% | 10.5% |
| Operating income | -$30.6M | -$46.4M | -$39.7M | -$13.5M |
| Operating margin | -5.2% | -7.2% | -6.0% | -1.8% |
| Net income | -$34.2M | -$125M | -$31.3M | -$23.4M |
| Net margin | -5.8% | -19.6% | -4.7% | -3.2% |
| EPS (diluted) | -$0.55 | -$2.03 | -$0.50 | -$0.37 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | $53.3M | $1.63M | $16.6M | $25.2M |
| Capital expenditures | $17.7M | $69.0M | $86.0M | $93.7M |
| Free cash flow | $35.7M | -$67.4M | -$69.4M | -$68.5M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $151M | $125M | $110M | $99.9M |
| Total assets | $1.49B | $1.50B | $1.52B | $1.61B |
| Total liabilities | $1.19B | $964M | $988M | $1.08B |
| Long-term debt | $467M | $527M | $513M | $523M |
| Shareholders' equity | $300M | $529M | $524M | $526M |
| Retained earnings | -$429M | -$554M | -$586M | -$609M |
| Shares (wtd avg diluted) | — | 62.5M | 62.9M | 63.6M |
Every figure is extracted from Atlanta Braves Holdings, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.